Safety and efficacy of avanafil, a new phosphodiesterase type-5 (PDE-5) inhibitor for treating erectile dysfunction

被引：6
|
作者：
Kaufman, JM
Dietrich, JW
机构：
来源：
JOURNAL OF UROLOGY | 2006年 / 175卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)33159-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
923
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [21] Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction
    Dorsey, Philip
    Keel, Christopher
    Klavens, Meghan
    Hellstrom, Wayne J. G.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1109 - 1122
  • [22] Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in type 1 diabetic patients with erectile dysfunction
    Ziegler, D
    Merfort, F
    Van Ahlen, H
    Reblin, T
    Neureither, M
    DIABETES, 2005, 54 : A127 - A127
  • [23] EFFICACY OF PDE-5 INHIBITORS IN ERECTILE DYSFUNCTION AFTER SPINAL CORD INJURY
    Konstantinidis, C.
    Kratiras, Z.
    Alexandros, T.
    Panagiotis, K.
    Thomas, C.
    Konstantinos, S.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S145 - S145
  • [24] Penile erectile responses to electric stimulation are enhanced by a new phosphodiesterase type-5 inhibitor
    Yu, JY
    Kang, KK
    Yoo, M
    Kwon, JW
    INTERNATIONAL JOURNAL OF UROLOGY, 2005, 12 (03) : 299 - 304
  • [25] PDE-5 inhibitors in treating men with erectile dysfunction and lower urinary tract symptoms
    Gamidov, S.
    Tazhetdinov, O.
    Pavlovichev, A.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 438 - 438
  • [26] The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction
    Ventimiglia, Eugenio
    Capogrosso, Paolo
    Montorsi, Francesco
    Salonia, Andrea
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (02) : 141 - 152
  • [27] Phosphodiesterase Type-5 Inhibitor Prescription Patterns in the United States Among Men With Erectile Dysfunction: An Update
    Mulhall, John P.
    Chopra, Ishveen
    Patel, Dipen
    Hassan, Tarek A.
    Tang, Wing Yu
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (05): : 941 - 948
  • [28] Avanafil, a Highly Selective Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction, Shows Good Safety Profiles for Retinal Function and Hemodynamics in Anesthetized Dogs
    Mochida, Hideki
    Yano, Koji
    Inoue, Hirotaka
    Yee, Shiyin
    Noto, Tsunehisa
    Kikkawa, Kohei
    JOURNAL OF UROLOGY, 2013, 190 (02): : 799 - 806
  • [29] TREATMENT OF ERECTILE DYSFUNCTION WITH PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5 INH) IN MALE PARTNER OF WOMEN WITH VAGINISMUS
    Ozkara, H.
    Akkus, E.
    Dinc, S.
    Alici, B.
    Tek, B.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 437 - 438
  • [30] Erectile dysfunction : Treatment with inhibitor drugs of type 5 phosphodiesterase
    不详
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2007, 53 (02): : 102 - 103
12345